REGULATORY

• Celgene’s CAR-T Liso-Cel Now in Line for Possible March Approval in Japan
  February 18, 2021

• Japan Launches COVID-19 Vaccination Program
  February 18, 2021

• MHLW Hints It Might Take 1 Year for Kobayashi Kako to Resume Operations
  February 17, 2021

• COVID-19 Vaccine Being Rolled Out for 40,000 Healthcare Workers in Japan
  February 17, 2021

• Pregnant Women Not Urged to “Make Efforts” to Get COVID-19 Vaccines
  February 16, 2021

• Chugai’s Blood-Based Genomic Profiling Test Now in Line for March OK
  February 16, 2021

• PAFSC Minutes for Pfizer Vaccine Review Due Out around Feb. 26
  February 16, 2021

• 17 Firms Get Approval for Cymbalta Generics, June Listing Eyed
  February 16, 2021

• PMDA Review Report: Pfizer Vaccine’s Efficacy for Variants Not Gauged in Clinical Trials, Continued Info Collection Needed
  February 16, 2021

• Japan to Start COVID-19 Vaccination on Feb. 17: PM Suga
  February 15, 2021

• PMDA to Expand MID-NET Use in Revised Guidelines from April
  February 15, 2021

• JCR’s Sakigake Designated Hunter Syndrome Med Up for PAFSC Review on Feb. 25
  February 15, 2021

• Pfizer Vaccine Deal Based on “Number of Doses”, Not Vials: Minister
  February 15, 2021

• Japan Approves Pfizer’s COVID-19 Vaccine, Rollout Set for Mid Week
  February 15, 2021

• Chuikyo OKs Flow of CEA-Based Re-Pricing, New Price Effective 3 Months after Announcements
  February 12, 2021

• MHLW Orders Pref. Govts to Strengthen Snap Inspections against Drug Makers after Kobayashi Kako Fiasco
  February 12, 2021

• Japan Now Sees Fewer Doses per Pfizer Vaccine Vial as Special Syringes Run Short
  February 12, 2021

• Incyte’s Pemigatinib Up for PAFSC Review on Feb. 22, March Approval Likely?
  February 10, 2021

• LDP Project Team Draws Up Proposal on COVID-19 Vaccination System
  February 10, 2021

• New Versions of Trelegy, Lasvic Approved for Listing on Feb. 18
  February 10, 2021

ページ

• « 先頭
• ‹ Prev
• …
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• …
• Next ›
• 最終 »